These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15256119)

  • 1. [Reversal of multidrug resistance of tumor cells by anti-mdr1 ribozyme].
    Gao P; Zhou GY; Zhang QH; Zhou CJ; Zhen JH; Sun YL
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):251-4. PubMed ID: 15256119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming multi-drug resistance by anti-MDR1 ribozyme.
    Wang H; Chen XP; Qiu FZ
    World J Gastroenterol; 2003 Jul; 9(7):1444-9. PubMed ID: 12854138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
    Kobayashi H; Takemura Y; Miyachi H
    Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA.
    Gao P; Zhou GY; Zhang QH; Li H; Mu K; Yuan YP; Zhang J; Wang BH
    Chin J Physiol; 2006 Apr; 49(2):96-103. PubMed ID: 16830791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme.
    Xing AY; Shi DB; Liu W; Chen X; Sun YL; Wang X; Zhang JP; Gao P
    Exp Mol Pathol; 2013 Jun; 94(3):481-5. PubMed ID: 23531420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter.
    Gao P; Zhou GY; Guo LL; Zhang QH; Zhen JH; Fang AJ; Lin XY
    Cancer Lett; 2007 Oct; 256(1):81-9. PubMed ID: 17637500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overcoming multi-drug resistance using anti-MDR1 ribozymes].
    Wang H; Chen XP; Qiu FZ
    Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):424-7. PubMed ID: 15144672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The reversion of multidrug resistance in tumour cell line MCF-7/Adr by ribozyme].
    Yuan Y; Zhang J; Zhou D
    Zhonghua Yi Xue Za Zhi; 1997 Jul; 77(7):494-6. PubMed ID: 9772447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversion of multidrug resistance in the P-glycoprotein positive breast cancer cell line (MCF-7/ADR) by introduction of hammerhead ribozyme.
    Yuan Y; Zhang J; Scanlon KJ; Lu Z; Qi G
    Chin Med Sci J; 1998 Mar; 13(1):24-8. PubMed ID: 11717919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex.
    Masuda Y; Kobayashi H; Holland JF; Ohnuma T
    Cancer Chemother Pharmacol; 1998; 42(1):9-16. PubMed ID: 9619752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of schisandrin B on reversing multidrug resistance in human breast cancer cells transfected with mdr1 gene].
    Li L; Wang T; Xu ZL; Yu Y; Chen W; Chen F
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1633-7. PubMed ID: 16185533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer].
    Yang XK; Xing H; Gao QL; Wang W; Wu SF; Lu YP; Wang SX; Ma D
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):425-8. PubMed ID: 14575561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors.
    Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM
    Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reversal of mdrl gene-dependent multidrug resistance in multidrug resistance human leukemia cell line K562/ADM using short hairpin RNA expression vectors].
    Gan HZ; Zhang GZ; Lu ZX; Pu LS; Yang SJ; Gao S; Zheng DM
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):383-7. PubMed ID: 17939403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells.
    Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY
    Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes.
    Kaszubiak A; Holm PS; Lage H
    Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells.
    Wu H; Hait WN; Yang JM
    Cancer Res; 2003 Apr; 63(7):1515-9. PubMed ID: 12670898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of adenovirus-mediated p53 gene on the reversal of multidrug resistance in breast cancer].
    He SZ; Qi XD; Zhang XM; Wang Y
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2935-7. PubMed ID: 18261311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.